INTC - Ultrathink Analysis (Refresh)

The Core Question Has Shifted

Three months ago, the question was whether Intel would survive. Today, the question is whether Intel at $68.50 is a rational investment or a momentum-fueled mirage.

The answer depends entirely on which frame you use.

Through the Aschenbrenner frame -- geopolitical optionality, semiconductor sovereignty, decade-long horizon -- Intel at $68.50 may be reasonable. You are buying a call option on the only American company capable of manufacturing leading-edge chips on US soil, backed by the largest industrial policy program since the New Deal. If the thesis is "America needs Intel to exist and will pay whatever it costs to ensure that," then the price is almost irrelevant. The US government has demonstrated willingness to commit $45B+ through the CHIPS Act, and the strategic logic only strengthens as Taiwan Strait tensions simmer.

Through the Buffett frame -- durable competitive advantage, consistent returns on capital, margin of safety -- Intel at $68.50 is absurd. The company generated zero operating profit on $53B of revenue. It destroyed 17% of per-share value through dilution. Free cash flow remains negative at -$5B. Book value per share actually declined despite a $14.4B equity raise. The stock trades at 2.85x book and 6.5x sales for a business that earns nothing. Where is the margin of safety? There is none. At $68.50, you are paying full price for a future that has not arrived.

The Dilution Problem Nobody Discusses

The most underappreciated fact about Intel's "improvement" is what it cost shareholders. Between FY2024 and FY2025, Intel issued $14.4B in new equity, increasing shares outstanding from 4.28B to 5.02B -- a 17.3% dilution. Let us think about what this means in plain terms.

If you owned 1% of Intel in January 2025, you now own 0.85% of Intel. The pie is bigger, but your slice is smaller. Revenue per share fell from $12.41 to $10.53. Operating cash flow per share was flat at $1.93 despite the headline improvement from $8.3B to $9.7B. Book value per share actually fell from $23.20 to $22.88.

This is the hidden cost of turnarounds financed by equity. Management saves the company by diluting the owners. It is the right thing to do when the alternative is bankruptcy, and Lip-Bu Tan was right to rebuild the balance sheet. But the stock price should reflect this dilution, and at $68.50 it does not. The market capitalization went from $201B to $344B -- a $143B increase in value assigned to a company that earned essentially nothing, issued $14.4B in stock, and still has negative free cash flow.

What exactly are investors paying for?

The Turnaround Illusion

There is a particular cognitive bias that afflicts turnaround investors: they confuse the rate of change with the level. Intel's operating margin went from -22% to 0%. That is a 22 percentage point improvement, and it sounds wonderful. But 0% is not a good operating margin. It is the margin of a company that covers its costs and nothing more. For context, AMD operates at 22% margins. TSMC operates at 42%. NVIDIA operates at 55%.

Intel improved from catastrophic to mediocre. The stock rallied 275% from its lows. That is the market pricing perfection from a position of imperfection.

Similarly, FCF improved from -$15.7B to -$5.0B. This is a $10.7B improvement, which sounds like enormous progress. But it was achieved primarily by cutting CapEx from $23.9B to $14.6B -- a $9.3B reduction. Intel did not generate more cash. It spent less. And the spending it cut was investment in the very fabs that are supposed to power the turnaround. This is not a contradiction you can simply wave away.

The Sum-of-Parts Reality Check

I built a sum-of-parts valuation, and the results should give every Intel bull pause. Even in the most optimistic scenario -- Intel Products at AMD-like multiples, the Foundry at meaningful option value, Mobileye and Altera at reasonable valuations -- the SOTP equity value comes to $35 per share after subtracting net debt.

The stock trades at $68.50. Nearly double the optimistic SOTP.

What this means: the market is either assigning Intel Products a much higher multiple than AMD (despite inferior margins and market share trends), or assigning the Foundry business a TSMC-like valuation (despite having essentially zero external leading-edge customers), or expecting a massive revenue inflection that has not materialized in four years of flat-to-declining top line.

None of these assumptions are supported by current fundamentals. They are projections of hope.

What Lip-Bu Tan Is Doing Right

Credit where it is due. Lip-Bu Tan has made several genuinely smart moves:

First, the CapEx rationalization. The previous regime was spending $25B+ per year building fabs as if Intel already had the customers to fill them. Tan cut this to $14.6B, which is still enormous but far more sustainable. You build capacity when you have demand, not before.

Second, the 13% insider ownership is meaningful. When the CEO has his personal wealth concentrated in the company, his incentives align with shareholders. This was conspicuously absent under previous management.

Third, the cultural shift toward customer-centricity. The old Intel was famously arrogant -- "we build what we want, you buy what we make." Tan is importing the TSMC philosophy of serving customers obsessively. If this cultural shift takes root, it could unlock foundry relationships that were impossible under the old regime.

Fourth, the willingness to take painful medicine. The equity raise was dilutive, but it removed the existential cash crisis. The dividend suspension freed up $3B+ annually. The cost cuts, while risky for an innovation company, showed discipline.

The Patient Path

Here is my honest assessment: Intel at $68.50 is a stock that has priced in 80% of the turnaround upside while only 20% of the turnaround has been achieved. The operating improvements are real. The balance sheet is stabilized. The management is credible. But the valuation offers no margin of safety for the enormous execution risk that remains.

At $28-35, this becomes interesting. At that level, you are paying near-SOTP for the existing businesses and getting the foundry option essentially free. You have margin of safety against execution stumbles. You are buying the turnaround at a price where even partial success generates attractive returns.

At $68.50, you are paying for perfection. And in the semiconductor industry, perfection is TSMC's job description, not Intel's -- at least not yet.

The upgrade from REJECT to WAIT is genuine. Intel is no longer uninvestable. It is simply overpriced. The two are different problems, and this one is solved by patience.

Munger once said: "The big money is not in the buying and selling, but in the waiting." For Intel, the waiting is for a price that offers margin of safety commensurate with the risk. That price is roughly half where the stock trades today.

The turnaround may work. The price is wrong. Wait.